Skip to content
AndzonBio2 – Neuroinflammation
  • About Us
  • Pipeline
  • Partner
  • News & Events
  • Contact
AndzonBio2 – Neuroinflammation
  • About Us
  • Pipeline
  • Partner
  • News & Events
  • Contact
AndzonBio2 – Neuroinflammation
  • May 13, 2026
  • News

AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise Announce a Collaboration to Develop First-in-Class Therapeutics for Neuroinflammation

Paris, France and Cambridge, UK, May 13, 2026 – AndzonBio2 today announced the signature of agreements with the ALBORADA Drug Discovery Institute (ADDI) at the University of Cambridge and Cambridge Enterprise to advance…

  • Mar 20, 2026
  • Events

Join AndzonBio2 team at BioEurope in Lisbon

  • Feb 3, 2026
  • News

AndzonBio2 Strengthens Scientific and Strategic Capabilities with New Advisory Board and Leadership Appointment.

Paris, February 3, 2026 – AndzonBio2, a biotechnology company focused on developing innovative therapeutic programs in neuroinflammation, today announced the formation of its Scientific Advisory Board (SAB), comprised of leading experts in neuroscience,…

  • Oct 23, 2025
  • News

AndzonBio2 emerges from stealth mode and announces initial €3M seed fundingto advance breakthrough treatments for neurological disorders.

Paris, France, October 23, 2025 – AndzonBio2 emerges from stealth mode and announces a €3M ($3.5M) seed funding from AdBio Partners, a venture capital company builder fund specialized in early-stage investments in life…

  • About Us
  • Pipeline
  • Partner
  • News & Events
  • Contact

© 2026 AndzonBio2. All rights reserved

  • Legal Notice
  • Terms and Conditions
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}